Glutamine supplementation favors weight loss in nondieting obese female patients. A pilot study

[1]  Gretchen A. Stevens,et al.  National, regional, and global trends in adult overweight and obesity prevalences , 2012, Population Health Metrics.

[2]  H. Berthoud.  The neurobiology of food intake in an obesogenic environment , 2012, Proceedings of the Nutrition Society.

[3]  J. Holst,et al.  Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. , 2011, The Journal of nutrition.

[4]  Á. Robles,et al.  The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients* , 2011, Critical care medicine.

[5]  R. Gambino,et al.  Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort , 2011, International Journal of Obesity.

[6]  R. Curi,et al.  Molecular mechanisms of glutamine action , 2005, Journal of cellular physiology.

[7]  J. Holst,et al.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.

[8]  J. Carvalheira,et al.  L-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity , 2007 .

[9]  H. O. Oudemans-van Straaten,et al.  Plasma glutamine depletion and patient outcome in acute ICU admissions , 2001, Intensive Care Medicine.

[10]  M. Feinglos,et al.  L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. , 1996, The Journal of nutrition.